The Food and Drug Administration (FDA) has issued a
communication strengthening an existing warning label that non-aspirin
nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a
heart attack or stroke. This includes prescribed and over-the-counter
non-aspirin NSAID labels.
Many people with hepatitis C
suffer from extrahepatic conditions of hepatitis C and may take NSAIDs
or medications that contain NSAIDs.
In a related story it was found
there was an increased risk of intracranial bleeding when taking
non-steroidal anti-inflammatory drugs (NSAIDs)—ibuprofen and
aspirin—during the first 30 days of taking a new prescription of an
anti-depressant. This was more common in men than in women. (BMJ.
Published online July 14, 2015.)
Read this FDA communication
carefully. Talk with your medical provider about what you should take,
how often and what are the alternatives that are safe to take.
Labels: FDA Warning, NSAIDS